ANXA1 promotes tumor immune evasion by binding PARP1 and upregulating Stat3-induced expression of PD-L1 in multiple cancers
D Xiao, T Zeng, W Zhu, ZZ Yu, W Huang, H Yi… - Cancer Immunology …, 2023 - AACR
The deregulation of Annexin A1 (ANXA1), a regulator of inflammation and immunity, leads to
cancer growth and metastasis. However, whether ANXA1 is involved in cancer …
cancer growth and metastasis. However, whether ANXA1 is involved in cancer …
Mouse Models of Metastasis and Dormancy
A Mahmoud, K Ganesh - Cold Spring …, 2024 - perspectivesinmedicine.cshlp.org
Metastasis is the ultimate and often lethal stage of cancer. Metastasis occurs in three phases
that may vary across individuals: First, dissemination from the primary tumor. Second, tumor …
that may vary across individuals: First, dissemination from the primary tumor. Second, tumor …
Alexidine dihydrochloride has broad-spectrum activities against diverse fungal pathogens
Invasive fungal infections due to Candida albicans, Aspergillus fumigatus, and Cryptococcus
neoformans constitute a substantial threat to hospitalized immunocompromised patients …
neoformans constitute a substantial threat to hospitalized immunocompromised patients …
[HTML][HTML] Expression and crucial role of long non-coding RNA FGD5-AS1 in human cancers
L Zhu, X Shi, X Yu, Z Wang, M Zhang… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Long non-coding RNAs (lncRNAs) are transcribed by RNA polymerase II and are longer
than 200 nucleotides. Several studies have revealed that lncRNAs are important regulators …
than 200 nucleotides. Several studies have revealed that lncRNAs are important regulators …
Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells
J Varshosaz, MA Davoudi… - Journal of liposome …, 2018 - Taylor & Francis
The aim of the present study was to prepare Herceptin targeted nanostructured lipid carriers
(NLCs) of docetaxel (DTX). Herceptin was conjugated by chemical and physical methods to …
(NLCs) of docetaxel (DTX). Herceptin was conjugated by chemical and physical methods to …
CellTrace™ Violet flow cytometric assay to assess cell proliferation
Abstract CellTrace™ Violet (CTV) is a powerful tool for tracking cell proliferation by
permanently binding cellular proteins and rendering the cell fluorescent. After cell division …
permanently binding cellular proteins and rendering the cell fluorescent. After cell division …
Cell viability and drug evaluation biosensing system based on disposable AuNPs/MWCNT nanocomposite modified screen-printed electrode for exocytosis dopamine …
MM Liu, FF Zhang, H Liu, MJ Wu, ZJ Liu, PF Huang - Talanta, 2023 - Elsevier
Cell viability, as an important index to evaluate drug effects, usually was measured by
tetrazolium colorimetric assay, playing a key role in drug development and drug screening …
tetrazolium colorimetric assay, playing a key role in drug development and drug screening …
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
C Boibessot, O Molina, G Lachance… - Clinical and …, 2022 - Wiley Online Library
Tumor‐associated macrophages (TAMs) support tumor progression within the tumor
microenvironment (TME). Many questions remain as to the origin, development, and function …
microenvironment (TME). Many questions remain as to the origin, development, and function …
Multi-component immune knockout: A strategy for studying the effective components of traditional Chinese medicine
H He, W Sun, J Chang, S Hu, J Yang, X Yi… - … of Chromatography A, 2023 - Elsevier
Periploca forrestii Schltr., a traditional Chinese medicine (TCM), is commonly used to treat
autoimmune diseases such as rheumatoid arthritis (RA). However, its mechanism, involving …
autoimmune diseases such as rheumatoid arthritis (RA). However, its mechanism, involving …
LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer
S Aini, S Bolati, W Ding, S Liu, P Su, S Aili… - …, 2022 - Taylor & Francis
Unlike other types of breast cancer, triple negative breast cancer (TNBC) does not respond
to therapies targeting human epidermal growth factor receptor-2 (HER2) or hormone …
to therapies targeting human epidermal growth factor receptor-2 (HER2) or hormone …